Chapter 28: Concepts of Care for Patients With Infectious Respiratory Problems

The content integrates interprofessional collaboration and evidence-based practice across multiple respiratory infections affecting different patient populations. Seasonal influenza is presented as a highly contagious viral pathogen spread through droplet transmission, producing systemic symptoms including fever, myalgia, and respiratory manifestations. Nursing interventions emphasize annual immunization, hand hygiene protocols, and patient education on symptom recognition and isolation measures. Antiviral pharmacotherapy with neuraminidase inhibitors demonstrates greatest efficacy when initiated early in the disease course, while supportive management addresses hydration, rest, and symptomatic relief. The chapter then examines pandemic respiratory infections such as H1N1 and COVID-19, which pose significant public health threats due to rapid global transmission and population susceptibility. These emerging infections require implementation of transmission-based precautions including droplet and aerosol isolation, appropriate personal protective equipment use, and coordinated vaccination campaigns. COVID-19 specifically presents with varied clinical manifestations ranging from respiratory symptoms to systemic complications including thrombotic and neurological sequelae, necessitating multimodal therapeutic approaches. Pneumonia serves as the gas exchange exemplar, illustrating how inflammatory consolidation of lung parenchyma impairs oxygenation and requiring differentiation among community-acquired, hospital-acquired, and ventilator-associated presentations. Diagnostic evaluation incorporates imaging and microbiological sampling to guide antimicrobial selection and oxygen therapy optimization. Tuberculosis exemplifies the infection concept, detailing airborne transmission of Mycobacterium tuberculosis and the distinction between latent infection and progressive active disease. Management emphasizes directly observed therapy with multidrug regimens to prevent treatment failure and resistance development, alongside airborne isolation precautions and patient adherence monitoring. Additional infectious entities including rhinosinusitis, peritonsillar abscess, inhalation anthrax, and endemic fungal infections are addressed with specific etiologies, clinical presentations, and treatment modalities. Throughout the chapter, nursing practice centers on early recognition of respiratory compromise, vaccination advocacy, appropriate precaution implementation, and comprehensive patient and family education to interrupt disease transmission and support recovery.